Allurion Technologies, Inc. (ALUR) vs HeartSciences Inc. (HSCS)
Allurion Technologies, Inc. and HeartSciences Inc. are both Medical Devices companies. HeartSciences Inc. is the larger, with a market value of $23.9M against $16.7M — 1.4× the size. HeartSciences Inc. grew revenue faster over the last twelve months: 131.9% against −55.5%. Allurion Technologies, Inc. has the higher net margin (−264.7% vs −48,621.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Allurion Technologies, Inc. leads on 10 and HeartSciences Inc. on 4.
Valuation
Profitability
| Metric | ALUR | HSCS | Medical Devices median |
|---|---|---|---|
| Gross margin | 52.70% | 18.01% | 56.01% |
| Operating margin | (211.21%) | (44,918.48%) | (15.03%) |
| Net margin | (264.74%) | (48,621.80%) | (20.40%) |
| Free cash flow margin | (180.19%) | (33,725.12%) | (7.24%) |
| Return on equity | 45.16% | (1,854.69%) | (15.32%) |
| Return on assets | (127.26%) | (201.67%) | (19.72%) |
| Return on invested capital | 0.00% | 0.00% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack